Association of vitamin D and its metabolites in patients with and without type 2 diabetes and their relationship to diabetes complications

• Main Authors: Alexandra E. Butler (Author), Soha R. Dargham (Author), Aishah Latif (Author), Haira R. Mokhtar (Author), Amal Robay (Author), Omar M. Chidiac (Author), Amin Jayyousi (Author), Jassim Al Suwaidi (Author), Ronald G. Crystal (Author), Charbel Abi Khalil (Author), Stephen L. Atkin (Author)
• Format: Book
• Published: SAGE Publishing, 2020-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 2040-6231; 10.1177/2040622320924159
• Keywords: Therapeutics. Pharmacology; RM1-950
• Source: Therapeutic Advances in Chronic Disease, Vol 11 (2020)

Background: Epidemiological studies have suggested that vitamin D deficiency is associated with the development of type 2 diabetes (T2DM) and is related to diabetes complications. This study was undertaken to determine the relationship between diabetes complications and cardiovascular risk factors with vitamin D 3 and its metabolites: 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ), 25-hydroxyvitamin D 3 (25(OH)D 3 ), 24,25-dihydroxyvitamin D 3 (24,25(OH) 2 D 3 ); and 25-hydroxy-3epi-vitamin D 3 (3epi25(OH)D 3 ). Methods: 750 Qatari subjects, 460 (61.3%) with and 290 (38.7%) without T2DM, who were not taking vitamin D 3 supplements, participated in this cross-sectional, observational study. Plasma concentrations of vitamin D 3 and its metabolites were measured by liquid chromatography tandem mass spectrometry analysis. Results: T2DM subjects had lower concentrations of all vitamin D 3 metabolites ( p < 0.001) except 3epi25(OH)D 3 ( p < 0.071). Males had higher concentrations of all vitamin D 3 metabolites ( p < 0.001). In the T2DM subjects, lower 25(OH)D 3 was associated with retinopathy ( p < 0.03) and dyslipidemia ( p < 0.04), but not neuropathy or vascular complications; lower 1,25(OH) 2 D 3 was associated with hypertension ( p < 0.009), dyslipidemia ( p < 0.003) and retinopathy ( p < 0.006), and coronary artery disease ( p < 0.012), but not neuropathy; lower 24,25(OH) 2 D 3 concentrations were associated with dyslipidemia alone ( p < 0.019); 3epi25(OH)D 3 associated with diabetic neuropathy alone ( p < 0.029). In nondiabetics, 25(OH)D 3 , 1,25(OH) 2 D 3 and 24,25(OH) 2 D 3 were associated with dyslipidemia ( p < 0.001, p < 0.001, p < 0.015, respectively) and lower 1,25(OH) 2 D 3 was associated with hypertension ( p < 0.001). Spearman's correlation showed 1,25(OH) 2 D 3 to be negatively correlated to age and diabetes duration. Conclusions: Different diabetes complications were associated with differing vitamin D parameters, with diabetic retinopathy related to lower 25(OH)D 3 and 1,25(OH) 2 D 3 levels, hypertension significantly associated with lower 1,25(OH) 2 D 3 , while dyslipidemia was associated with lower 25(OH)D 3 , 1,25(OH) 2 D 3 and 24,25(OH) 2 D 3. While 25(OH)D metabolites were lower in females, there was not an exaggeration in complications.